Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
---|
09/04/1997 | WO1997032026A1 Adapter molecules for targeting viral particles to cells |
09/04/1997 | WO1997031942A1 Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use |
09/04/1997 | WO1997031929A1 Novel erythromycin derivatives, method for preparing same, and use thereof as drugs |
09/04/1997 | WO1997031903A1 Azole compounds endowed with antimycotic activity for human and veterinary use |
09/04/1997 | WO1997031651A1 Porcine reproductive and respiratory syndrome vaccine |
09/04/1997 | WO1997031643A1 LOW pH GERMICIDAL IODINE COMPOSITIONS HAVING ENHANCED STABILITY |
09/04/1997 | WO1997031642A1 Anti-hiv agent |
09/04/1997 | WO1997031630A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
09/04/1997 | CA2248320A1 Broad spectrum antimicrobial peptides containing a tryptophan triplet and methods of use |
09/04/1997 | CA2247390A1 Azole compounds endowed with antimycotic activity for human and veterinary use |
09/04/1997 | CA2247370A1 Use of hexahydrolupulones as antibacterial and anticancer agents |
09/03/1997 | EP0792885A2 Derivatives of 12,13-epoxy-tylosin and processes of manufacture thereof |
09/03/1997 | EP0792654A2 Articles with antibacterial activity for use as medical or surgical aids |
09/03/1997 | EP0792370A1 INTERLEUKIN-1 $g(b) CONVERTING ENZYME LIKE APOPTOSIS PROTEASE-3 AND 4 |
09/03/1997 | EP0792365A1 Immunogens for stimulating mucosal immunity |
09/03/1997 | EP0792359A1 Transcription factor e2f-4 |
09/03/1997 | EP0792358A2 A polynucleotide tuberculosis vaccine |
09/03/1997 | EP0792354A1 Targeted t lymphocytes |
09/03/1997 | EP0792347A1 Methods for producing enhanced antigenic helicobacter sp. and vaccines comprising same |
09/03/1997 | EP0792283A1 SYNTHESIS OF PEPTIDE NUCLEIC ACIDS (PNAs) AND ANALOGUES VIA SUBMONOMER APPROACH |
09/03/1997 | EP0792278A1 Tumor necrosis factor-gamma |
09/03/1997 | EP0792273A1 Bicyclic oxazine and thiazine oxazolidinone antibacterials |
09/03/1997 | EP0792168A1 Novel tumor suppressor gene, hic-1 |
09/03/1997 | EP0792167A1 Monofunctional and/or polyfunctional polylysine conjugates |
09/03/1997 | EP0792162A1 Use of antibodies to block the effects of gram-positive bacteria and mycobacteria |
09/03/1997 | EP0792148A1 Therapeutic quassinoid preparations with antineoplastic, antiviral, and herbistatic activity |
09/03/1997 | EP0792146A1 Inactivation of pathogens using hydroxymethylamines |
09/03/1997 | CN1158609A Imidazole derivative |
09/03/1997 | CN1158571A Remedy for endotoxinemia andmultiple organ failure induced thereby |
09/03/1997 | CN1158566A Pharmaceutical compsn. for the prevention and/or treatment of viral infections and optionally inflammations as well as a method for treatment thereof |
09/03/1997 | CN1158552A Cells bearing CD4 decoy receptors and related molecules and methods |
09/03/1997 | CN1158333A Method for preparing cynnematin antibiotic |
09/02/1997 | US5663467 Synthesis of cyclopropylacetylene |
09/02/1997 | US5663380 Cysteine protease inhibitors containing heterocyclic leaving groups |
09/02/1997 | US5663341 Process for making HIV protease inhibitors |
09/02/1997 | US5663340 N-(2-amino-4,6-dichloropyrimidine-5-yl)formamide, and a process for its preparation |
09/02/1997 | US5663337 Pharmaceutically active benzoquinazoline compounds |
09/02/1997 | US5663334 Process for preparing pyrimidyl imidazoles |
09/02/1997 | US5663331 Bactericides |
09/02/1997 | US5663320 Processes for the diastereoselective separation of nucleoside analogue synthetic intermediates |
09/02/1997 | US5663312 Chemical intermediates for rna and dna for gene expression |
09/02/1997 | US5663209 Compounds for the suppression of HIV Tat transactivation |
09/02/1997 | US5663200 Carbamoyl peptide derivatives as viricides |
09/02/1997 | US5663161 Anti-viral triaza compounds |
09/02/1997 | US5663159 Prodrugs of phosphonates |
09/02/1997 | US5663154 Viricides, hiv, hepatitis |
09/02/1997 | US5663150 Cyclopentane-β-amino acid tripeptides |
09/02/1997 | US5662929 Bactericides using liposomes |
09/02/1997 | CA1339422C Crystalline (5r,6s)-2-carbamoyloxymethyl-6-¬(1r)-hydroxyethyl|-2-penem-carboxylic acid and its pharmaceutical formulation |
09/02/1997 | CA1339421C Cephalosporin derivatives and processes for their preparation |
09/02/1997 | CA1339418C Cephalosporin antibiotics |
09/02/1997 | CA1339415C Detection and treatment of infections with immunoconjugates |
08/28/1997 | WO1997031119A1 Methods and compositions for protective and therapeutic genetic immunization |
08/28/1997 | WO1997031117A2 A human cytomegalovirus combined antigen and its use |
08/28/1997 | WO1997031115A2 Synthetic hiv genes |
08/28/1997 | WO1997031114A2 Polynucleotides and aminoacid sequences from staphylococcus aureus |
08/28/1997 | WO1997031019A2 Antipathogenic peptides and compositions comprising them |
08/28/1997 | WO1997031002A1 Fused pyrrolo(2,3-c)carbazole-6-ones which potentiate activity of gamma interferon |
08/28/1997 | WO1997031001A1 Possibly substituted 8-cyano-1-cyclopropyl-7-(2,8-diazabicyclo-[4.3.0]-nonan-8-yl)-6-fluoro-1,4-dihydro-4-oxo-3-quinolin carboxylic acids and their derivatives |
08/28/1997 | WO1997030995A1 Antibiotic oxazolidinone derivatives |
08/28/1997 | WO1997030979A1 New antiviral substituted pyrimidinedione homocarbocyclic nucleoside derivatives and methods for the preparation thereof and compositions containing the same as active ingredients |
08/28/1997 | WO1997030976A1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
08/28/1997 | WO1997030716A1 Anti-helicobacter vaccine complex |
08/28/1997 | WO1997022346A3 Use of sugar derivatives as antimicrobial, antimycotic and/or antiviral active substances |
08/28/1997 | WO1997019702A3 Powdery iodine complexes |
08/28/1997 | DE19600939C1 Verfahren zur Trennung von IgG und IgA A method for separating IgG and IgA |
08/28/1997 | CA2247025A1 Antipathogenic peptides and compositions comprising them |
08/28/1997 | CA2246359A1 Methods and compositions for protective and therapeutic genetic immunization |
08/28/1997 | CA2238478A1 Preparation of (s)-decahydroisoquinoline-3-carboxylic acid t-butylamide |
08/27/1997 | EP0791654A1 Polypeptides corresponding to the amino acid sequences of proteins p57 or p9.5 of Borna disease virus, nucleic acid fragments coding therefore and their use for diagnostic and immunization purposes |
08/27/1997 | EP0791594A2 2-Aryl-5,11-dihydro-6H-dipyrido 3,2-b:2',3'-e 1,4 diazepines and their use for the preparation of pharmaceutical compositions for the treatment of HIV infection |
08/27/1997 | EP0791580A2 Novel derivatives of 3-bromo and 3,3-dibromo-4-oxo-1-azetidines, processes for the preparation thereof and their use |
08/27/1997 | EP0791065A1 Protein targeting into hiv virions based on hiv-1 vpr fusion molecules |
08/27/1997 | EP0791061A1 Animals with targeted gene disruption |
08/27/1997 | EP0791056A2 Lipid-splitting enzyme |
08/27/1997 | EP0791007A1 Antifungal sordaridin derivatives |
08/27/1997 | EP0790992A1 A new physically stable solid form of a fluoroquinolone |
08/27/1997 | EP0790836A1 Serially passaged african green monkey kidney cells |
08/27/1997 | EP0790833A1 Process for identifying para cation channel modulators |
08/27/1997 | EP0790828A1 Use of phosphonoacetic or-formic acids against human herpes virus -7 (hhv-7) |
08/27/1997 | EP0745090B1 Oligonucleotides with anti-respiratory syncytial virus activity |
08/27/1997 | EP0679152B1 Anti-androgenic cyclo and bicyclo alkenes |
08/27/1997 | EP0625967B1 N,n'-substituted imidocarbonimidic diamides derived from hydroxylamines |
08/27/1997 | EP0544895B1 Method for inactivating pathogens in a body fluid |
08/27/1997 | EP0527724B1 Compositions and treatments for pneumonia in animals |
08/27/1997 | EP0524205B1 Live vaccines |
08/27/1997 | EP0476066B1 3'-azido-2',3'-dideoxy-5-methylcytidine anti-viral composition |
08/27/1997 | CN1158121A Indolizine SPLA2 inhibitors |
08/27/1997 | CN1158120A Process for making antimicrobial compounds |
08/27/1997 | CN1158119A Legionella specific antibiotic, a mcroorganism producing the antibiotic and a process for producing the same |
08/27/1997 | CA2198559A1 Body showing an antibacterial effect for application as a medical or surgical aid |
08/26/1997 | US5661161 Administering to treat cancer in mammals |
08/26/1997 | US5661156 Administering to inhibit the growth of pathogenic fungi, to induce immunosuppression, and to treat carcinogenic tumors in humans and animals |
08/26/1997 | US5661155 Treatment of cancer with pharmaceutically active benzoquinazoline compounds |
08/26/1997 | US5661151 Posaconazole and salts |
08/26/1997 | US5661131 Administering a vibrio toxin-binding oligosaccharide bound to an absorbent solid support by a nonpeptidyl spacer arm; elimination from the gastrointestinal tract |
08/26/1997 | US5661006 Polynucleotides genetic engineering a vaccines |
08/26/1997 | US5661004 Lymphotoxin-β, lymphotoxin-β complexes, pharmaceutical preparations and therapeutic uses thereof |
08/26/1997 | US5660860 Acyclovir in water dispersible tablet; herpes virus treatment |
08/26/1997 | US5660842 Administering at least one monoglyceride of fatty acid as bactericides |